## **Core Concept**
Imiquimod is a topical **immune response modifier** used in the treatment of certain skin conditions, including genital warts and superficial basal cell carcinoma. It acts by activating the immune system through the stimulation of **toll-like receptors** (TLR7 and TLR8), which are crucial in the recognition of viral RNA. This results in the production of pro-inflammatory cytokines.

## **Why the Correct Answer is Right**
The correct route of administration for imiquimod is **topical**. This is because imiquimod is primarily used for its local effects on the skin, where it can modulate the immune response to treat conditions like genital warts. Its formulation as a cream allows for direct application to the affected area, minimizing systemic side effects.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Intravenous (IV) administration is not suitable for imiquimod as it is used for local treatment of skin conditions and does not require systemic administration.
- **Option B:** Oral administration is not used for imiquimod because it is not necessary for the drug's mechanism of action and could lead to unnecessary systemic side effects.
- **Option D:** Intramuscular (IM) injection is also not appropriate for imiquimod as it is designed for local, not systemic, effects.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that imiquimod is often used for the treatment of **genital warts** and **superficial basal cell carcinoma**. It works by enhancing the body's immune response against these conditions. A notable side effect can be local skin reactions, which usually resolve on their own.

## **Correct Answer:** . Topical.